OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings	60
Medicines Delivery Proximity Programme (PEMProxi) survey results	43
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients	38
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease	22
Medicine shortages in France: a 6-year retrospective study in a university medical centre	21
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study	19
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations	13
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years	13
Advanced therapy medicinal products	13
Medical device resources for hospital pharmacists	13
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?	12
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent	11
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence	11
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey	10
Empowering European hospital pharmacists in the face of heart failure	10
The threatened medicines information pharmacist!	10
Implementation and effectiveness of pharmacist-led interviews at patient hospital admission in a rheumatology department	10
Design and validation of a predictive equation to estimate unbound valproic acid concentration	9
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report	9
EJHP’s impact factor moves on up	8
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze	8
Optimisation of the quality of care for patients with severe asthma: ASfarMA project	8
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology	7
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings	7
Public consultation for European health data space is open	7

Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis	6
Analysis of the clinical characteristics of dabigatran-induced oesophagitis	6
Beta-lactam allergy in patients: an antibiotic stewardship challenge	6
Antifungal prophylaxis against invasiveCandidaandAspergillusinfection in adult heart transplant recipients: protocol for a systematic review and meta-analysis	6
Thoughts on the shortage of vinflunine: could we have done more?	6
¹⁷⁷Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods	6
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome	6
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients	6
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report	6
EMA guidance for industry to prevent and mitigate medicine shortages	5
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations	5
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence	5
Medical management of first trimester miscarriage: a quality improvement initiative	5
The end of an era!	5
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness	5
Show how you keep antibiotics working during this year’s EAAD	5
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts	5
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report	5
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort	5
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C	5
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 2023	4
Compliance with status epilepticus management protocol and effect on clinical outcomes in children with status epilepticus	4
Haemolytic anaemia induced by flutamide: a case report	4
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey	4
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management	4
‘To crush or not to crush, that is the question!’ An algorithm can help with the proper administration of solid oral medicines in patients where the oral route is compromised	4
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time	4
Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results	4
Penicillin allergy that persisted after 66 years: case report	4
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients	4
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology	4
Pancytopenia in a patient treated with fusidic acid and niraparib: a case report	4
Availability of antidotes in Moroccan hospitals: a national survey	4
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy	4
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report	4
Clinical trials	4
RETRACTED: Specific features of rational pharmacotherapy in elderly patients	4
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab	4
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases	3
An antidote network in Spain, a tool to improve antidote availability in hospitals	3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge	3
Medicine packaging pictograms in the context of the electronic product information (ePI) proposal	3
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy	3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document	3
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients	3
Capecitabine: guaranteed access in adjuvant treatment of breast cancer	3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags	3
Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit	3
Tocilizumab in COVID-19 management: addressing time of starting treatment	3
Switching of anti-migraine antibodies: effectiveness or regression to the mean?	3

Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports	3
Update on the hospital pharmacist profile: from clinical practice to management	3
Infectious diseases and antimicrobial resistance	3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing	3
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?	3
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 2	3
Role of EMA for crises strengthened	3
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings	3
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison	3
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review	3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 2022	3
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series	3
Results of EAHP’s 2023 shortages survey	2
Antimicrobial resistance in Nigeria: challenges and charting the way forward	2
Antimicrobial resistance: a major priority for global focus	2
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1	2
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection	2
When gravimetry is debated by sponsors of clinical studies	2
Study of therapeutic patient education practices in French renal transplantation centres	2
Medication-related problems in critical care survivors: a systematic review	2
European health data space proposal launched	2
Looking back and looking forward	2
Fixed drug eruption after pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus andHaemophilus influenzaetype b combined vaccine in an infant	2
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals	2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation	2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding	2
Evaluation of resources for effective decision-making about drug manipulation	2
Use of simulation for education in hospital pharmaceutical technologies: a systematic review	2
Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data	2
Access to medicines	2
Spread awareness, stop resistance – getting ready for WAAW and EAAD	2
Welcome to this online edition	2
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies	2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques	2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment	2
Comparison of adverse drug reactions of statins in China from 1989 to 2019	2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp	2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations	2
Defining a new term: defensive hospital pharmacy practices	2
Implementation of pharmacists’ monitoring for intravenous drug compatibility	2
Factors associated with potential drug–drug interactions in psychiatric inpatients	2
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use	2
Ceftaroline combination therapy for methicillin resistant coagulase negativeStaphylococcusbacteraemia and endocarditis	2
Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population	2
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD	2
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?	2
Primary care electronic medication record discrepancies in patients starting treatment at a hospital-based ambulatory care pharmacy and impact on prevalence of potential drug–drug interactions	2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials	2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy	2
Liquid antimicrobials: a national analysis of critical shortages	2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study	2
Introduction to an online only issue	2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins	2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review	2
Digital health	2
Financial impact of the hospital pharmacy’s participation in clinical trials	2
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-19	2
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients	2
Public information on shortages in the EU/EEA: improvements made between 2018 and 2020	2
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?	2
Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia	2
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin	2
To maximise impact, hospital pharmacists need to increase visibility	2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia	2
Patient safety culture and medication safety in European intensive care units: a focus group study	2
The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs	2
Importance of medication reconciliation, even in the absence of positive data	2
BCWA: don’t we love abbreviations and acronyms!	2
Sulperazon-induced acute reactive thrombocytopenia during treatment of systemic lupus erythematosus: a case report	2